Andreas Bauman
YOU?
Author Swipe
View article: Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis
Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis Open
Metastatic insulinoma is a rare malignant neuroendocrine tumor characterized by inappropriate insulin secretion, resulting in life-threatening hypoglycemia, which is often difficult to treat. There is currently very limited information abo…
View article: Improved Quality Control of [177Lu]Lu-PSMA I&T
Improved Quality Control of [177Lu]Lu-PSMA I&T Open
Background: Targeted radionuclide therapy with [ 177 Lu]Lu-PSMA I&T (Zadavotide guraxetan) has proven high efficacy and safety in treating patients with advanced prostate cancer worldwide. Several methods to determine the radiochemical pur…
View article: Safety, Biodistribution, and Radiation Dosimetry of <sup>68</sup>Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
Safety, Biodistribution, and Radiation Dosimetry of <sup>68</sup>Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study Open
Preclinical and preliminary clinical evidence indicates that radiolabeled somatostatin (sst) receptor antagonists perform better than agonists in detecting neuroendocrine tumors (NETs). We performed a prospective phase I/II study to evalua…
View article: Development of <sup>68</sup>Ga- and <sup>89</sup>Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET
Development of <sup>68</sup>Ga- and <sup>89</sup>Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET Open
68Ga- and 89Zr-radiolabeled [Lys40-(AHX-DFO)NH2]exendin-4 exhibit characteristics comparable or superior to the clinically tested reference compound [Lys40-(AHX-DTPA-111In)NH2]exendin-4 and, thus, represent potential new tracers for the im…